-89%

est. 2Y upside i

HealthcareSeed

Eternal provides lifelong athletes with an expert team of health and performance advisors to keep them going in the activities they love for as long as possible.

Rank

#1605

Sector

Healthcare Technology / Longevity

Est. Liquidity

~6Y

Data Quality

Data: Low

Eternal presents a moderate upside opportunity for a job seeker, driven by its innovative, integrated approach to athlete longevity and expansion into primary care within a massive, underpenetrated market.

Last updated: March 10, 2026

Bull (25%)+250%

Eternal successfully captures a significant share of the high-performance athlete longevity market, leveraging its integrated diagnostics and personalized coaching to achieve rapid member growth. Strategic partnerships with sports organizations or insurers accelerate adoption, pushing its valuation to $350M+ by 2028, reflecting strong differentiation and a clear path to profitability.

Base (40%)+75%

Eternal continues to grow steadily within its niche, expanding its clinic footprint and refining its membership offerings. It secures a Series A or B round at a healthy valuation, but faces ongoing competition from well-funded players like Function Health and Superpower, leading to a valuation of approximately $175M by 2028.

Bear (35%)-90%

Intense competition from larger, better-funded rivals like Function Health and Superpower, coupled with high customer acquisition costs and regulatory hurdles, slows Eternal's growth significantly. The company struggles to raise follow-on funding, leading to a down round or a low-value acquisition, where the $13.25M liquidation preference for seed investors wipes out most common stock value.

Est. time to liquidity~6.0 years

Preference Stack Risk

moderate

Investors hold $13.25M in liquidation preferences, representing 13.25% of the estimated $100M current valuation.

Dilution Risk

high

As an early-stage company with $13.25M raised, Eternal will require several more significant funding rounds (Series A, B, C, etc.) to scale, leading to substantial future dilution for common stock holders.

Secondary Liquidity

none

As a seed-stage, privately held company, there is currently no active secondary market or tender offers for employee equity.

View all 4 open roles at Eternal →

Last updated: February 22, 2026

Questions to Ask at the Interview

Strategic questions based on Eternal's data — designed to show you've done your homework.

  • 1

    “Given the significant funding and valuations of competitors like Function Health and Superpower, how does Eternal plan to differentiate and compete for market share and talent in the next 12-24 months?”

  • 2

    “With the expansion into comprehensive primary care, what are the key metrics (e.g., member retention, LTV/CAC, average revenue per user) the company is prioritizing to demonstrate scalable growth and prepare for a Series A or B round?”

  • 3

    “Considering the $13.25M seed funding and the need for future capital, what is the anticipated timeline for the next funding round, and how is the company thinking about managing dilution for early employees?”

Community

Valuation Sentiment

Our model estimates -89% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.